Skip to main content
Lupus science & medicine
Mer-tyrosine kinase: a novel susceptibility gene for SLE related end-stage renal disease.
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria.
Association of COVID-19 pandemic-related concern and health routine changes with functioning among individuals with systemic lupus erythematosus.
Incidence rates of systemic lupus erythematosus in the USA: estimates from a meta-analysis of the Centers for Disease Control and Prevention national lupus registries.
Patient and provider perceptions of a novel cognitive functioning report for patients with systemic lupus erythematosus: a qualitative study.
Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis.
Increased alloreactive and autoreactive antihuman leucocyte antigen antibodies associated with systemic lupus erythematosus and rheumatoid arthritis.
Patient-reported outcome measures for use in clinical trials of SLE: a review.
DNA methylation 101: what is important to know about DNA methylation and its role in SLE risk and disease heterogeneity.
Lupus community panel proposals for optimising clinical trials: 2018.
